MedPath

Adenobio N.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler

Phase 2
Conditions
Ischemic Heart Disease
Interventions
First Posted Date
2012-05-08
Last Posted Date
2012-09-07
Lead Sponsor
Adenobio N.V
Target Recruit Count
75
Registration Number
NCT01593644
Locations
🇫🇷

Centre Hospitalier de Compiègne, Compiègne, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.